-
Economic Impact of Experiential Negative Symptoms Among Patients Living With Schizophrenia: Medical Expenditure Panel Survey
Mar 10, 2025, 14:00 PM -
Leveraging Machine Learning to Assess the Association of Rash and Survival in Patients With Advanced NSCLC
Mar 10, 2025, 14:00 PM -
Evaluation of a Novel Approach to Deduplication of Trial Registry Records in Systematic Reviews
Mar 10, 2025, 14:00 PM -
Burden of COVID-19 on Health-Related Quality of Life in Immunocompromised Adult Participants From the EPIC-IC Trial
Mar 10, 2025, 14:00 PM -
Assessment of Willingness and Influencing Factors for COVID-19 Booster Vaccination Among Residents of Hong Kong in the Post-Pandemic Context
Mar 10, 2025, 14:00 PM -
Impact of Herpes Zoster Ophthalmicus on Healthcare Utilization and Patient Reported Outcomes: Results from a Multicenter Cohort Study
Mar 10, 2025, 14:00 PM -
Foundational Insights and Costs of Care Associated With Perioperative Ticagrelor Management for Patients Undergoing Coronary Artery Bypass Graft Surgery: A Medical Chart Audit Review
Mar 10, 2025, 14:00 PM -
Systematic Literature Review of Unmet Needs and Burden of Disease in Generalized Anxiety Disorder (GAD)
Mar 10, 2025, 14:00 PM -
Is Poor Adherence to Good Modeling Practices Making Us Worry Too Much About Effect Modifiers? A Case Study in Moderate to Severe Plaque Psoriasis
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Among Fabry Disease Patients in the U.S.: Insights From a Real-World Retrospective Study
Mar 10, 2025, 14:00 PM -
Real-World Cancer Recurrence and Overall Survival Outcomes in Muscle-Invasive Bladder Cancer (MIBC) Patients Treated With Radical Cystectomy (RC): A Retrospective Surveillance, Epidemiology, and End Results-Medicare Study
Mar 10, 2025, 14:00 PM -
A German Claims Database Analysis of Epidemiology, Treatment Patterns, and Healthcare Resource Utilization of Patients with Primary Biliary Cholangitis (PBC)
Mar 10, 2025, 14:00 PM -
Validation of Real-World Pathologic Complete Response in Early Stage Triple Negative Breast Cancer
Mar 10, 2025, 14:00 PM -
Review of US Cost Effectiveness Evaluations for Antibody Drug Conjugates (ADCs) in Oncology
Mar 10, 2025, 14:00 PM -
Heredofamilial Amyloidosis Due to Transthyretin (hATTR): Cost Analysis From the Perspective of the Public Health Sector in Mexico
Mar 10, 2025, 14:00 PM -
A Large Language Model Approach for Evaluating Real-World Evidence in FDA Approvals
Mar 10, 2025, 14:00 PM -
Self-Reported Health-Related Quality-of-Life in Adolescent Patients with Complex Chronic Health Conditions from A Longitudinal Registry Study in Los Angeles County
Mar 10, 2025, 14:00 PM -
Meta-analysis of Economic Evaluations of Higher-Valent Pneumococcal Conjugate Vaccines For Seniors in High-Income Countries
Mar 10, 2025, 14:00 PM -
Development of a Patient Reported Outcome Measure for GastroIntestinal Recoveryafter Surgery (PRO-diGI)
Mar 10, 2025, 14:00 PM -
Leveraging a Novel Mixed-Methods Approach to Deepen Insights From Exit Interviews and Trial Data in a Randomized Trial of Cancer Cachexia
Mar 10, 2025, 14:00 PM